Regulatory UK MHRA authorises orforglipron private prescription PharmaphorumEli Lilly has announced that orforglipron (Foundayo) is now available to be prescribed for eligible adults via private prescription.Metabolic & GLP-1Read full story pharminent August 24, 2026 (Last updated: September 1, 2026) Pharmaphorum Eli Lilly has announced that orforglipron (Foundayo) is now available to be prescribed for eligible adults via private prescription. Metabolic & GLP-1 Read full story Post navigation Previous: Johnson & Johnson Wins EU Approval for Tecvayli-Daratumumab in Second-Line MyelomaNext: Johnson & Johnson’s multiple myeloma treatment secures EC approval Related Stories Regulatory Scholar Rock’s muscle-targeting SMA therapy Isemblyd lands FDA approval pharminent September 14, 2026 Regulatory Psychedelic therapies ride wave of public favor into FDA hearing pharminent September 14, 2026 Regulatory Bayer’s Hyrnuo set for the NSCLC frontlines on accelerated FDA label expansion pharminent September 10, 2026